Safety, tolerability and adherence to the serum-free formulation of subcutaneous interferon β-1a in patients with relapsing—remitting multiple sclerosis in real-life settings: interim data from the prospective, observational, multi-centre STAR study: P915


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles